[1]
R. . Gallego-Pinazo, “Local Safety Concerns of Repited Dexamethasone Intravitreal Implant (Ozurdex®) For Macular Diseases ”,  J. Ocul. Dis. Ther., vol. 1, no. 1, pp. 10–14, Apr. 2013.